Interaction Checker

Interaksi Brimonidin

Brimonidin (Alphagan), golongan agonis alfa-adrenergik, memiliki 275 interaksi terdokumentasi dalam label FDA dan lembar fakta yang kami indeks: 1 mayor, 273 moderat, 1 minor, dan 0 dengan label yang melaporkan tidak ada interaksi bermakna. Setiap entri di bawah ini mengutip kalimat yang mendasarinya. Halaman obat ini adalah titik awal, bukan putusan untuk situasi Anda.

Interaksi dari label

Interaksi mayor (1)

  • HialuronidaseMayor

    • Hyaluronidase should not be used to enhance the absorption and dispersion of dopamine and/or alpha agonist drugs ( 7.2 ) (label Hialuronidase, Interaksi obat)

Interaksi moderat (273)

  • AliskirenantihipertensiModerat

    Antihypertensives/Cardiac Glycosides Because brimonidine tartrate ophthalmic solution 0.1% and 0.15% may reduce blood pressure, caution in using drugs such as antihypertensives and/or cardiac glycosides with brimonidine tartrate ophthalmic solution 0.1% and 0.15% is advised. (label Brimonidin, Interaksi obat)

  • AlkoholAlkoholModerat

    CNS Depressants Although specific drug interaction studies have not been conducted with brimonidine tartrate ophthalmic solution 0.1% and 0.15%, the possibility of an additive or potentiating effect with CNS depressants (alcohol, barbiturates, opiates, sedatives, or anesthetics) should be considered. (label Brimonidin, Interaksi obat)

  • AlprazolambenzodiazepinModerat

    Use with CNS depressants may result in an additive or potentiating effect. (label Brimonidin, Interaksi obat)

  • Amiloriddiuretik hemat kaliumModerat

    Antihypertensives/Cardiac Glycosides Because brimonidine tartrate ophthalmic solution 0.1% and 0.15% may reduce blood pressure, caution in using drugs such as antihypertensives and/or cardiac glycosides with brimonidine tartrate ophthalmic solution 0.1% and 0.15% is advised. (label Brimonidin, Interaksi obat)

  • Amitriptilinantidepresan trisiklikModerat

    Use with CNS depressants may result in an additive or potentiating effect. (label Brimonidin, Interaksi obat)

  • Amlodipinpenghambat kanal kalsium dihidropiridinModerat

    Antihypertensives/Cardiac Glycosides Because brimonidine tartrate ophthalmic solution 0.1% and 0.15% may reduce blood pressure, caution in using drugs such as antihypertensives and/or cardiac glycosides with brimonidine tartrate ophthalmic solution 0.1% and 0.15% is advised. (label Brimonidin, Interaksi obat)

  • Amlodipin dan atorvastatinpenghambat kanal kalsium dihidropiridinModerat

    Antihypertensives/Cardiac Glycosides Because brimonidine tartrate ophthalmic solution 0.1% and 0.15% may reduce blood pressure, caution in using drugs such as antihypertensives and/or cardiac glycosides with brimonidine tartrate ophthalmic solution 0.1% and 0.15% is advised. (label Brimonidin, Interaksi obat)

  • Amlodipin dan benazeprilpenghambat kanal kalsium dihidropiridinModerat

    Antihypertensives/Cardiac Glycosides Because brimonidine tartrate ophthalmic solution 0.1% and 0.15% may reduce blood pressure, caution in using drugs such as antihypertensives and/or cardiac glycosides with brimonidine tartrate ophthalmic solution 0.1% and 0.15% is advised. (label Brimonidin, Interaksi obat)

  • Amlodipin dan olmesartanpenghambat kanal kalsium dihidropiridinModerat

    Antihypertensives/Cardiac Glycosides Because brimonidine tartrate ophthalmic solution 0.1% and 0.15% may reduce blood pressure, caution in using drugs such as antihypertensives and/or cardiac glycosides with brimonidine tartrate ophthalmic solution 0.1% and 0.15% is advised. (label Brimonidin, Interaksi obat)

  • Amlodipin dan valsartanpenghambat kanal kalsium dihidropiridinModerat

    Antihypertensives/Cardiac Glycosides Because brimonidine tartrate ophthalmic solution 0.1% and 0.15% may reduce blood pressure, caution in using drugs such as antihypertensives and/or cardiac glycosides with brimonidine tartrate ophthalmic solution 0.1% and 0.15% is advised. (label Brimonidin, Interaksi obat)

  • Amoksapinantidepresan trisiklikModerat

    Use with CNS depressants may result in an additive or potentiating effect. (label Brimonidin, Interaksi obat)

  • AripiprazolantipsikotikModerat

    Use with CNS depressants may result in an additive or potentiating effect. (label Brimonidin, Interaksi obat)

  • Asam etakrinatdiuretik loopModerat

    Antihypertensives/Cardiac Glycosides Because brimonidine tartrate ophthalmic solution 0.1% and 0.15% may reduce blood pressure, caution in using drugs such as antihypertensives and/or cardiac glycosides with brimonidine tartrate ophthalmic solution 0.1% and 0.15% is advised. (label Brimonidin, Interaksi obat)

  • Asam valproatantikonvulsanModerat

    Use with CNS depressants may result in an additive or potentiating effect. (label Brimonidin, Interaksi obat)

  • Asebutololpenyekat betaModerat

    Antihypertensives/Cardiac Glycosides Because brimonidine tartrate ophthalmic solution 0.1% and 0.15% may reduce blood pressure, caution in using drugs such as antihypertensives and/or cardiac glycosides with brimonidine tartrate ophthalmic solution 0.1% and 0.15% is advised. (label Brimonidin, Interaksi obat)

  • AsenapinantipsikotikModerat

    Use with CNS depressants may result in an additive or potentiating effect. (label Brimonidin, Interaksi obat)

  • Atenololpenyekat betaModerat

    Antihypertensives/Cardiac Glycosides Because brimonidine tartrate ophthalmic solution 0.1% and 0.15% may reduce blood pressure, caution in using drugs such as antihypertensives and/or cardiac glycosides with brimonidine tartrate ophthalmic solution 0.1% and 0.15% is advised. (label Brimonidin, Interaksi obat)

  • Atenolol dan klortalidonpenyekat betaModerat

    Antihypertensives/Cardiac Glycosides Because brimonidine tartrate ophthalmic solution 0.1% and 0.15% may reduce blood pressure, caution in using drugs such as antihypertensives and/or cardiac glycosides with brimonidine tartrate ophthalmic solution 0.1% and 0.15% is advised. (label Brimonidin, Interaksi obat)

  • AzelastinantihistaminModerat

    Use with CNS depressants may result in an additive or potentiating effect. (label Brimonidin, Interaksi obat)

  • Azelastin dan flutikasonantihistaminModerat

    Use with CNS depressants may result in an additive or potentiating effect. (label Brimonidin, Interaksi obat)

  • Azilsartanpenghambat reseptor angiotensin II (ARB)Moderat

    Antihypertensives/Cardiac Glycosides Because brimonidine tartrate ophthalmic solution 0.1% and 0.15% may reduce blood pressure, caution in using drugs such as antihypertensives and/or cardiac glycosides with brimonidine tartrate ophthalmic solution 0.1% and 0.15% is advised. (label Brimonidin, Interaksi obat)

  • Baklofenpelemas ototModerat

    Use with CNS depressants may result in an additive or potentiating effect. (label Brimonidin, Interaksi obat)

  • Beladona dan opiumopioidModerat

    Use with CNS depressants may result in an additive or potentiating effect. (label Brimonidin, Interaksi obat)

  • Benazeprilpenghambat ACEModerat

    Antihypertensives/Cardiac Glycosides Because brimonidine tartrate ophthalmic solution 0.1% and 0.15% may reduce blood pressure, caution in using drugs such as antihypertensives and/or cardiac glycosides with brimonidine tartrate ophthalmic solution 0.1% and 0.15% is advised. (label Brimonidin, Interaksi obat)

  • Benazepril dan hidroklorotiazidpenghambat ACEModerat

    Antihypertensives/Cardiac Glycosides Because brimonidine tartrate ophthalmic solution 0.1% and 0.15% may reduce blood pressure, caution in using drugs such as antihypertensives and/or cardiac glycosides with brimonidine tartrate ophthalmic solution 0.1% and 0.15% is advised. (label Brimonidin, Interaksi obat)

  • Betaksololpenyekat betaModerat

    Antihypertensives/Cardiac Glycosides Because brimonidine tartrate ophthalmic solution 0.1% and 0.15% may reduce blood pressure, caution in using drugs such as antihypertensives and/or cardiac glycosides with brimonidine tartrate ophthalmic solution 0.1% and 0.15% is advised. (label Brimonidin, Interaksi obat)

  • Bisoprololpenyekat betaModerat

    Antihypertensives/Cardiac Glycosides Because brimonidine tartrate ophthalmic solution 0.1% and 0.15% may reduce blood pressure, caution in using drugs such as antihypertensives and/or cardiac glycosides with brimonidine tartrate ophthalmic solution 0.1% and 0.15% is advised. (label Brimonidin, Interaksi obat)

  • Bisoprolol dan hidroklorotiazidpenyekat betaModerat

    Antihypertensives/Cardiac Glycosides Because brimonidine tartrate ophthalmic solution 0.1% and 0.15% may reduce blood pressure, caution in using drugs such as antihypertensives and/or cardiac glycosides with brimonidine tartrate ophthalmic solution 0.1% and 0.15% is advised. (label Brimonidin, Interaksi obat)

  • BrekspiprazolantipsikotikModerat

    Use with CNS depressants may result in an additive or potentiating effect. (label Brimonidin, Interaksi obat)

  • BrivarasetamantikonvulsanModerat

    Use with CNS depressants may result in an additive or potentiating effect. (label Brimonidin, Interaksi obat)

  • Bromfeniramin, pseudoefedrin, dan dekstrometorfanantihistaminModerat

    Use with CNS depressants may result in an additive or potentiating effect. (label Brimonidin, Interaksi obat)

  • BuprenorfinopioidModerat

    Use with CNS depressants may result in an additive or potentiating effect. (label Brimonidin, Interaksi obat)

  • Buprenorfin dan naloksonopioidModerat

    Use with CNS depressants may result in an additive or potentiating effect. (label Brimonidin, Interaksi obat)

  • BupropionantidepresanModerat

    Caution is advised in patients taking tricyclic antidepressants which can affect the metabolism and uptake of circulating amines. (label Brimonidin, Interaksi obat)

  • Butalbital dan parasetamolbarbituratModerat

    Use with CNS depressants may result in an additive or potentiating effect. (label Brimonidin, Interaksi obat)

  • Butalbital, aspirin, dan kafeinbarbituratModerat

    Use with CNS depressants may result in an additive or potentiating effect. (label Brimonidin, Interaksi obat)

  • Butalbital, aspirin, kafein, dan kodeinbarbituratModerat

    Use with CNS depressants may result in an additive or potentiating effect. (label Brimonidin, Interaksi obat)

  • Butalbital, parasetamol, dan kafeinbarbituratModerat

    Use with CNS depressants may result in an additive or potentiating effect. (label Brimonidin, Interaksi obat)

  • Butalbital, parasetamol, kafein, dan kodeinbarbituratModerat

    Use with CNS depressants may result in an additive or potentiating effect. (label Brimonidin, Interaksi obat)

  • ButorfanolopioidModerat

    Use with CNS depressants may result in an additive or potentiating effect. (label Brimonidin, Interaksi obat)

  • Dantrolenpelemas ototModerat

    Use with CNS depressants may result in an additive or potentiating effect. (label Brimonidin, Interaksi obat)

  • Daridoreksantsedatif-hipnotikModerat

    Use with CNS depressants may result in an additive or potentiating effect. (label Brimonidin, Interaksi obat)

  • DeksklorfeniraminantihistaminModerat

    Use with CNS depressants may result in an additive or potentiating effect. (label Brimonidin, Interaksi obat)

  • Deksmedetomidinagonis alfa-adrenergikModerat

    Use with CNS depressants may result in an additive or potentiating effect. (label Brimonidin, Interaksi obat)

  • Desflurananestetik umumModerat

    Use with CNS depressants may result in an additive or potentiating effect. (label Brimonidin, Interaksi obat)

  • Desipraminantidepresan trisiklikModerat

    Use with CNS depressants may result in an additive or potentiating effect. (label Brimonidin, Interaksi obat)

  • DesvenlafaksinSNRIModerat

    Caution is advised in patients taking tricyclic antidepressants which can affect the metabolism and uptake of circulating amines. (label Brimonidin, Interaksi obat)

  • DiazepambenzodiazepinModerat

    Use with CNS depressants may result in an additive or potentiating effect. (label Brimonidin, Interaksi obat)

  • DifenhidraminantihistaminModerat

    Use with CNS depressants may result in an additive or potentiating effect. (label Brimonidin, Interaksi obat)

  • Digoksinglikosida digitalisModerat

    Antihypertensives/Cardiac Glycosides Because brimonidine tartrate ophthalmic solution 0.1% and 0.15% may reduce blood pressure, caution in using drugs such as antihypertensives and/or cardiac glycosides with brimonidine tartrate ophthalmic solution 0.1% and 0.15% is advised. (label Brimonidin, Interaksi obat)

  • Diltiazempenghambat kanal kalsiumModerat

    Antihypertensives/Cardiac Glycosides Because brimonidine tartrate ophthalmic solution 0.1% and 0.15% may reduce blood pressure, caution in using drugs such as antihypertensives and/or cardiac glycosides with brimonidine tartrate ophthalmic solution 0.1% and 0.15% is advised. (label Brimonidin, Interaksi obat)

  • DimenhidrinatantihistaminModerat

    Use with CNS depressants may result in an additive or potentiating effect. (label Brimonidin, Interaksi obat)

  • Divalproeks (valproat)antikonvulsanModerat

    Use with CNS depressants may result in an additive or potentiating effect. (label Brimonidin, Interaksi obat)

  • Doksazosinpenyekat alfaModerat

    Antihypertensives/Cardiac Glycosides Because brimonidine tartrate ophthalmic solution 0.1% and 0.15% may reduce blood pressure, caution in using drugs such as antihypertensives and/or cardiac glycosides with brimonidine tartrate ophthalmic solution 0.1% and 0.15% is advised. (label Brimonidin, Interaksi obat)

  • Doksepinantidepresan trisiklikModerat

    Use with CNS depressants may result in an additive or potentiating effect. (label Brimonidin, Interaksi obat)

  • DoksilaminantihistaminModerat

    Use with CNS depressants may result in an additive or potentiating effect. (label Brimonidin, Interaksi obat)

  • Doksilamin dan piridoksinantihistaminModerat

    Use with CNS depressants may result in an additive or potentiating effect. (label Brimonidin, Interaksi obat)

  • DronabinolkanabinoidModerat

    Use with CNS depressants may result in an additive or potentiating effect. (label Brimonidin, Interaksi obat)

  • Droperidolantagonis dopaminModerat

    Use with CNS depressants may result in an additive or potentiating effect. (label Brimonidin, Interaksi obat)

  • DuloksetinSNRIModerat

    Caution is advised in patients taking tricyclic antidepressants which can affect the metabolism and uptake of circulating amines. (label Brimonidin, Interaksi obat)

  • EluksadolinopioidModerat

    Use with CNS depressants may result in an additive or potentiating effect. (label Brimonidin, Interaksi obat)

  • Enalaprilpenghambat ACEModerat

    Antihypertensives/Cardiac Glycosides Because brimonidine tartrate ophthalmic solution 0.1% and 0.15% may reduce blood pressure, caution in using drugs such as antihypertensives and/or cardiac glycosides with brimonidine tartrate ophthalmic solution 0.1% and 0.15% is advised. (label Brimonidin, Interaksi obat)

  • Enalapril dan hidroklorotiazidpenghambat ACEModerat

    Antihypertensives/Cardiac Glycosides Because brimonidine tartrate ophthalmic solution 0.1% and 0.15% may reduce blood pressure, caution in using drugs such as antihypertensives and/or cardiac glycosides with brimonidine tartrate ophthalmic solution 0.1% and 0.15% is advised. (label Brimonidin, Interaksi obat)

  • Enalaprilatpenghambat ACEModerat

    Antihypertensives/Cardiac Glycosides Because brimonidine tartrate ophthalmic solution 0.1% and 0.15% may reduce blood pressure, caution in using drugs such as antihypertensives and/or cardiac glycosides with brimonidine tartrate ophthalmic solution 0.1% and 0.15% is advised. (label Brimonidin, Interaksi obat)

  • Eplerenonantagonis aldosteronModerat

    Antihypertensives/Cardiac Glycosides Because brimonidine tartrate ophthalmic solution 0.1% and 0.15% may reduce blood pressure, caution in using drugs such as antihypertensives and/or cardiac glycosides with brimonidine tartrate ophthalmic solution 0.1% and 0.15% is advised. (label Brimonidin, Interaksi obat)

  • EsitalopramSSRIModerat

    Caution is advised in patients taking tricyclic antidepressants which can affect the metabolism and uptake of circulating amines. (label Brimonidin, Interaksi obat)

  • EslikarbazepinantikonvulsanModerat

    Use with CNS depressants may result in an additive or potentiating effect. (label Brimonidin, Interaksi obat)

  • EstazolambenzodiazepinModerat

    Use with CNS depressants may result in an additive or potentiating effect. (label Brimonidin, Interaksi obat)

  • Eszopiklonsedatif-hipnotikModerat

    Use with CNS depressants may result in an additive or potentiating effect. (label Brimonidin, Interaksi obat)

  • Etomidatanestetik umumModerat

    Use with CNS depressants may result in an additive or potentiating effect. (label Brimonidin, Interaksi obat)

  • EtosuksimidantikonvulsanModerat

    Use with CNS depressants may result in an additive or potentiating effect. (label Brimonidin, Interaksi obat)

  • FelbamatantikonvulsanModerat

    Use with CNS depressants may result in an additive or potentiating effect. (label Brimonidin, Interaksi obat)

  • Felodipinpenghambat kanal kalsium dihidropiridinModerat

    Antihypertensives/Cardiac Glycosides Because brimonidine tartrate ophthalmic solution 0.1% and 0.15% may reduce blood pressure, caution in using drugs such as antihypertensives and/or cardiac glycosides with brimonidine tartrate ophthalmic solution 0.1% and 0.15% is advised. (label Brimonidin, Interaksi obat)

  • Fenelzinpenghambat MAOModerat

    Monoamine oxidase inhibitors may result in increased hypotension. (label Brimonidin, Interaksi obat)

  • FenitoinantikonvulsanModerat

    Use with CNS depressants may result in an additive or potentiating effect. (label Brimonidin, Interaksi obat)

  • FenobarbitalbarbituratModerat

    Use with CNS depressants may result in an additive or potentiating effect. (label Brimonidin, Interaksi obat)

  • Fenobarbital, hiosiamin, atropin, dan skopolaminbarbituratModerat

    Use with CNS depressants may result in an additive or potentiating effect. (label Brimonidin, Interaksi obat)

  • Fenoksibenzaminpenyekat alfaModerat

    Antihypertensives/Cardiac Glycosides Because brimonidine tartrate ophthalmic solution 0.1% and 0.15% may reduce blood pressure, caution in using drugs such as antihypertensives and/or cardiac glycosides with brimonidine tartrate ophthalmic solution 0.1% and 0.15% is advised. (label Brimonidin, Interaksi obat)

  • FentanilopioidModerat

    Use with CNS depressants may result in an additive or potentiating effect. (label Brimonidin, Interaksi obat)

  • Fentermin dan topiramatstimulan SSPModerat

    Use with CNS depressants may result in an additive or potentiating effect. (label Brimonidin, Interaksi obat)

  • Flibanserindepresan SSPModerat

    Use with CNS depressants may result in an additive or potentiating effect. (label Brimonidin, Interaksi obat)

  • FlufenazinantipsikotikModerat

    Use with CNS depressants may result in an additive or potentiating effect. (label Brimonidin, Interaksi obat)

  • FlumazenilbenzodiazepinModerat

    Use with CNS depressants may result in an additive or potentiating effect. (label Brimonidin, Interaksi obat)

  • FluoksetinSSRIModerat

    Caution is advised in patients taking tricyclic antidepressants which can affect the metabolism and uptake of circulating amines. (label Brimonidin, Interaksi obat)

  • FluvoksaminSSRIModerat

    Caution is advised in patients taking tricyclic antidepressants which can affect the metabolism and uptake of circulating amines. (label Brimonidin, Interaksi obat)

  • FosfenitoinantikonvulsanModerat

    Use with CNS depressants may result in an additive or potentiating effect. (label Brimonidin, Interaksi obat)

  • Fosinoprilpenghambat ACEModerat

    Antihypertensives/Cardiac Glycosides Because brimonidine tartrate ophthalmic solution 0.1% and 0.15% may reduce blood pressure, caution in using drugs such as antihypertensives and/or cardiac glycosides with brimonidine tartrate ophthalmic solution 0.1% and 0.15% is advised. (label Brimonidin, Interaksi obat)

  • Fosinopril dan hidroklorotiazidpenghambat ACEModerat

    Antihypertensives/Cardiac Glycosides Because brimonidine tartrate ophthalmic solution 0.1% and 0.15% may reduce blood pressure, caution in using drugs such as antihypertensives and/or cardiac glycosides with brimonidine tartrate ophthalmic solution 0.1% and 0.15% is advised. (label Brimonidin, Interaksi obat)

  • Furosemiddiuretik loopModerat

    Antihypertensives/Cardiac Glycosides Because brimonidine tartrate ophthalmic solution 0.1% and 0.15% may reduce blood pressure, caution in using drugs such as antihypertensives and/or cardiac glycosides with brimonidine tartrate ophthalmic solution 0.1% and 0.15% is advised. (label Brimonidin, Interaksi obat)

  • GabapentinantikonvulsanModerat

    Use with CNS depressants may result in an additive or potentiating effect. (label Brimonidin, Interaksi obat)

  • Guanfasinagonis alfa-adrenergikModerat

    Use with CNS depressants may result in an additive or potentiating effect. (label Brimonidin, Interaksi obat)

  • HaloperidolantipsikotikModerat

    Use with CNS depressants may result in an additive or potentiating effect. (label Brimonidin, Interaksi obat)

  • HidralazinvasodilatorModerat

    Antihypertensives/Cardiac Glycosides Because brimonidine tartrate ophthalmic solution 0.1% and 0.15% may reduce blood pressure, caution in using drugs such as antihypertensives and/or cardiac glycosides with brimonidine tartrate ophthalmic solution 0.1% and 0.15% is advised. (label Brimonidin, Interaksi obat)

  • Hidroklorotiaziddiuretik tiazidModerat

    Antihypertensives/Cardiac Glycosides Because brimonidine tartrate ophthalmic solution 0.1% and 0.15% may reduce blood pressure, caution in using drugs such as antihypertensives and/or cardiac glycosides with brimonidine tartrate ophthalmic solution 0.1% and 0.15% is advised. (label Brimonidin, Interaksi obat)

  • HidrokodonopioidModerat

    Use with CNS depressants may result in an additive or potentiating effect. (label Brimonidin, Interaksi obat)

  • Hidrokodon dan homatropinopioidModerat

    Use with CNS depressants may result in an additive or potentiating effect. (label Brimonidin, Interaksi obat)

  • Hidrokodon dan ibuprofenopioidModerat

    Use with CNS depressants may result in an additive or potentiating effect. (label Brimonidin, Interaksi obat)

  • Hidrokodon dan klorfeniraminopioidModerat

    Use with CNS depressants may result in an additive or potentiating effect. (label Brimonidin, Interaksi obat)

  • Hidrokodon dan parasetamolopioidModerat

    Use with CNS depressants may result in an additive or potentiating effect. (label Brimonidin, Interaksi obat)

  • HidroksizinantihistaminModerat

    Use with CNS depressants may result in an additive or potentiating effect. (label Brimonidin, Interaksi obat)

  • HidromorfonopioidModerat

    Use with CNS depressants may result in an additive or potentiating effect. (label Brimonidin, Interaksi obat)

  • IloperidonantipsikotikModerat

    Use with CNS depressants may result in an additive or potentiating effect. (label Brimonidin, Interaksi obat)

  • Imipraminantidepresan trisiklikModerat

    Use with CNS depressants may result in an additive or potentiating effect. (label Brimonidin, Interaksi obat)

  • Indapamiddiuretik tiazidModerat

    Antihypertensives/Cardiac Glycosides Because brimonidine tartrate ophthalmic solution 0.1% and 0.15% may reduce blood pressure, caution in using drugs such as antihypertensives and/or cardiac glycosides with brimonidine tartrate ophthalmic solution 0.1% and 0.15% is advised. (label Brimonidin, Interaksi obat)

  • Irbesartanpenghambat reseptor angiotensin II (ARB)Moderat

    Antihypertensives/Cardiac Glycosides Because brimonidine tartrate ophthalmic solution 0.1% and 0.15% may reduce blood pressure, caution in using drugs such as antihypertensives and/or cardiac glycosides with brimonidine tartrate ophthalmic solution 0.1% and 0.15% is advised. (label Brimonidin, Interaksi obat)

  • Irbesartan dan hidroklorotiazidpenghambat reseptor angiotensin II (ARB)Moderat

    Antihypertensives/Cardiac Glycosides Because brimonidine tartrate ophthalmic solution 0.1% and 0.15% may reduce blood pressure, caution in using drugs such as antihypertensives and/or cardiac glycosides with brimonidine tartrate ophthalmic solution 0.1% and 0.15% is advised. (label Brimonidin, Interaksi obat)

  • Isoflurananestetik umumModerat

    Use with CNS depressants may result in an additive or potentiating effect. (label Brimonidin, Interaksi obat)

  • IsoniazidantibiotikModerat

    Monoamine oxidase inhibitors may result in increased hypotension. (label Brimonidin, Interaksi obat)

  • Isosorbid dinitrat dan hidralazinnitratModerat

    Antihypertensives/Cardiac Glycosides Because brimonidine tartrate ophthalmic solution 0.1% and 0.15% may reduce blood pressure, caution in using drugs such as antihypertensives and/or cardiac glycosides with brimonidine tartrate ophthalmic solution 0.1% and 0.15% is advised. (label Brimonidin, Interaksi obat)

  • Isradipinpenghambat kanal kalsium dihidropiridinModerat

    Antihypertensives/Cardiac Glycosides Because brimonidine tartrate ophthalmic solution 0.1% and 0.15% may reduce blood pressure, caution in using drugs such as antihypertensives and/or cardiac glycosides with brimonidine tartrate ophthalmic solution 0.1% and 0.15% is advised. (label Brimonidin, Interaksi obat)

  • Kanabidiol (obat resep)antikonvulsanModerat

    Use with CNS depressants may result in an additive or potentiating effect. (label Brimonidin, Interaksi obat)

  • Kandesartanpenghambat reseptor angiotensin II (ARB)Moderat

    Antihypertensives/Cardiac Glycosides Because brimonidine tartrate ophthalmic solution 0.1% and 0.15% may reduce blood pressure, caution in using drugs such as antihypertensives and/or cardiac glycosides with brimonidine tartrate ophthalmic solution 0.1% and 0.15% is advised. (label Brimonidin, Interaksi obat)

  • Kandesartan dan hidroklorotiazidpenghambat reseptor angiotensin II (ARB)Moderat

    Antihypertensives/Cardiac Glycosides Because brimonidine tartrate ophthalmic solution 0.1% and 0.15% may reduce blood pressure, caution in using drugs such as antihypertensives and/or cardiac glycosides with brimonidine tartrate ophthalmic solution 0.1% and 0.15% is advised. (label Brimonidin, Interaksi obat)

  • Kaptoprilpenghambat ACEModerat

    Antihypertensives/Cardiac Glycosides Because brimonidine tartrate ophthalmic solution 0.1% and 0.15% may reduce blood pressure, caution in using drugs such as antihypertensives and/or cardiac glycosides with brimonidine tartrate ophthalmic solution 0.1% and 0.15% is advised. (label Brimonidin, Interaksi obat)

  • KarbamazepinantikonvulsanModerat

    Use with CNS depressants may result in an additive or potentiating effect. (label Brimonidin, Interaksi obat)

  • KarbinoksaminantihistaminModerat

    Use with CNS depressants may result in an additive or potentiating effect. (label Brimonidin, Interaksi obat)

  • KariprazinantipsikotikModerat

    Use with CNS depressants may result in an additive or potentiating effect. (label Brimonidin, Interaksi obat)

  • Karisoprodolpelemas ototModerat

    Use with CNS depressants may result in an additive or potentiating effect. (label Brimonidin, Interaksi obat)

  • Karvedilolpenyekat betaModerat

    Antihypertensives/Cardiac Glycosides Because brimonidine tartrate ophthalmic solution 0.1% and 0.15% may reduce blood pressure, caution in using drugs such as antihypertensives and/or cardiac glycosides with brimonidine tartrate ophthalmic solution 0.1% and 0.15% is advised. (label Brimonidin, Interaksi obat)

  • Ketamindepresan SSPModerat

    Use with CNS depressants may result in an additive or potentiating effect. (label Brimonidin, Interaksi obat)

  • KlemastinantihistaminModerat

    Use with CNS depressants may result in an additive or potentiating effect. (label Brimonidin, Interaksi obat)

  • KlobazambenzodiazepinModerat

    Use with CNS depressants may result in an additive or potentiating effect. (label Brimonidin, Interaksi obat)

  • Klomipraminantidepresan trisiklikModerat

    Use with CNS depressants may result in an additive or potentiating effect. (label Brimonidin, Interaksi obat)

  • KlonazepambenzodiazepinModerat

    Use with CNS depressants may result in an additive or potentiating effect. (label Brimonidin, Interaksi obat)

  • Klonidinagonis alfa-adrenergikModerat

    Use with CNS depressants may result in an additive or potentiating effect. (label Brimonidin, Interaksi obat)

  • KlorazepatbenzodiazepinModerat

    Use with CNS depressants may result in an additive or potentiating effect. (label Brimonidin, Interaksi obat)

  • KlordiazepoksidbenzodiazepinModerat

    Use with CNS depressants may result in an additive or potentiating effect. (label Brimonidin, Interaksi obat)

  • Klordiazepoksid dan klidiniumbenzodiazepinModerat

    Use with CNS depressants may result in an additive or potentiating effect. (label Brimonidin, Interaksi obat)

  • KlorfeniraminantihistaminModerat

    Use with CNS depressants may result in an additive or potentiating effect. (label Brimonidin, Interaksi obat)

  • Klorotiaziddiuretik tiazidModerat

    Antihypertensives/Cardiac Glycosides Because brimonidine tartrate ophthalmic solution 0.1% and 0.15% may reduce blood pressure, caution in using drugs such as antihypertensives and/or cardiac glycosides with brimonidine tartrate ophthalmic solution 0.1% and 0.15% is advised. (label Brimonidin, Interaksi obat)

  • KlorpromazinantipsikotikModerat

    Use with CNS depressants may result in an additive or potentiating effect. (label Brimonidin, Interaksi obat)

  • Klortalidondiuretik tiazidModerat

    Antihypertensives/Cardiac Glycosides Because brimonidine tartrate ophthalmic solution 0.1% and 0.15% may reduce blood pressure, caution in using drugs such as antihypertensives and/or cardiac glycosides with brimonidine tartrate ophthalmic solution 0.1% and 0.15% is advised. (label Brimonidin, Interaksi obat)

  • Klorzoksazonpelemas ototModerat

    Use with CNS depressants may result in an additive or potentiating effect. (label Brimonidin, Interaksi obat)

  • KlozapinantipsikotikModerat

    Use with CNS depressants may result in an additive or potentiating effect. (label Brimonidin, Interaksi obat)

  • KodeinopioidModerat

    Use with CNS depressants may result in an additive or potentiating effect. (label Brimonidin, Interaksi obat)

  • KuetiapinantipsikotikModerat

    Use with CNS depressants may result in an additive or potentiating effect. (label Brimonidin, Interaksi obat)

  • Kuinaprilpenghambat ACEModerat

    Antihypertensives/Cardiac Glycosides Because brimonidine tartrate ophthalmic solution 0.1% and 0.15% may reduce blood pressure, caution in using drugs such as antihypertensives and/or cardiac glycosides with brimonidine tartrate ophthalmic solution 0.1% and 0.15% is advised. (label Brimonidin, Interaksi obat)

  • Kuinapril dan hidroklorotiazidpenghambat ACEModerat

    Antihypertensives/Cardiac Glycosides Because brimonidine tartrate ophthalmic solution 0.1% and 0.15% may reduce blood pressure, caution in using drugs such as antihypertensives and/or cardiac glycosides with brimonidine tartrate ophthalmic solution 0.1% and 0.15% is advised. (label Brimonidin, Interaksi obat)

  • Labetalolpenyekat betaModerat

    Antihypertensives/Cardiac Glycosides Because brimonidine tartrate ophthalmic solution 0.1% and 0.15% may reduce blood pressure, caution in using drugs such as antihypertensives and/or cardiac glycosides with brimonidine tartrate ophthalmic solution 0.1% and 0.15% is advised. (label Brimonidin, Interaksi obat)

  • LakosamidantikonvulsanModerat

    Use with CNS depressants may result in an additive or potentiating effect. (label Brimonidin, Interaksi obat)

  • Lemboreksantsedatif-hipnotikModerat

    Use with CNS depressants may result in an additive or potentiating effect. (label Brimonidin, Interaksi obat)

  • LevetirasetamantikonvulsanModerat

    Use with CNS depressants may result in an additive or potentiating effect. (label Brimonidin, Interaksi obat)

  • LevomilnasipranSNRIModerat

    Caution is advised in patients taking tricyclic antidepressants which can affect the metabolism and uptake of circulating amines. (label Brimonidin, Interaksi obat)

  • LevorfanolopioidModerat

    Use with CNS depressants may result in an additive or potentiating effect. (label Brimonidin, Interaksi obat)

  • LinezolidantibiotikModerat

    Monoamine oxidase inhibitors may result in increased hypotension. (label Brimonidin, Interaksi obat)

  • Lisinoprilpenghambat ACEModerat

    Antihypertensives/Cardiac Glycosides Because brimonidine tartrate ophthalmic solution 0.1% and 0.15% may reduce blood pressure, caution in using drugs such as antihypertensives and/or cardiac glycosides with brimonidine tartrate ophthalmic solution 0.1% and 0.15% is advised. (label Brimonidin, Interaksi obat)

  • Lisinopril dan hidroklorotiazidpenghambat ACEModerat

    Antihypertensives/Cardiac Glycosides Because brimonidine tartrate ophthalmic solution 0.1% and 0.15% may reduce blood pressure, caution in using drugs such as antihypertensives and/or cardiac glycosides with brimonidine tartrate ophthalmic solution 0.1% and 0.15% is advised. (label Brimonidin, Interaksi obat)

  • Lofeksidinagonis alfa-adrenergikModerat

    Use with CNS depressants may result in an additive or potentiating effect. (label Brimonidin, Interaksi obat)

  • LoksapinantipsikotikModerat

    Use with CNS depressants may result in an additive or potentiating effect. (label Brimonidin, Interaksi obat)

  • LorazepambenzodiazepinModerat

    Use with CNS depressants may result in an additive or potentiating effect. (label Brimonidin, Interaksi obat)

  • Losartanpenghambat reseptor angiotensin II (ARB)Moderat

    Antihypertensives/Cardiac Glycosides Because brimonidine tartrate ophthalmic solution 0.1% and 0.15% may reduce blood pressure, caution in using drugs such as antihypertensives and/or cardiac glycosides with brimonidine tartrate ophthalmic solution 0.1% and 0.15% is advised. (label Brimonidin, Interaksi obat)

  • Losartan dan hidroklorotiazidpenghambat reseptor angiotensin II (ARB)Moderat

    Antihypertensives/Cardiac Glycosides Because brimonidine tartrate ophthalmic solution 0.1% and 0.15% may reduce blood pressure, caution in using drugs such as antihypertensives and/or cardiac glycosides with brimonidine tartrate ophthalmic solution 0.1% and 0.15% is advised. (label Brimonidin, Interaksi obat)

  • LumateperonantipsikotikModerat

    Use with CNS depressants may result in an additive or potentiating effect. (label Brimonidin, Interaksi obat)

  • LurasidonantipsikotikModerat

    Use with CNS depressants may result in an additive or potentiating effect. (label Brimonidin, Interaksi obat)

  • MekamilaminantihipertensiModerat

    Antihypertensives/Cardiac Glycosides Because brimonidine tartrate ophthalmic solution 0.1% and 0.15% may reduce blood pressure, caution in using drugs such as antihypertensives and/or cardiac glycosides with brimonidine tartrate ophthalmic solution 0.1% and 0.15% is advised. (label Brimonidin, Interaksi obat)

  • MeklizinantihistaminModerat

    Use with CNS depressants may result in an additive or potentiating effect. (label Brimonidin, Interaksi obat)

  • Meprobamatdepresan SSPModerat

    Use with CNS depressants may result in an additive or potentiating effect. (label Brimonidin, Interaksi obat)

  • MetadonopioidModerat

    Use with CNS depressants may result in an additive or potentiating effect. (label Brimonidin, Interaksi obat)

  • Metaksalonpelemas ototModerat

    Use with CNS depressants may result in an additive or potentiating effect. (label Brimonidin, Interaksi obat)

  • MetildopaantihipertensiModerat

    Antihypertensives/Cardiac Glycosides Because brimonidine tartrate ophthalmic solution 0.1% and 0.15% may reduce blood pressure, caution in using drugs such as antihypertensives and/or cardiac glycosides with brimonidine tartrate ophthalmic solution 0.1% and 0.15% is advised. (label Brimonidin, Interaksi obat)

  • Metilen birupenghambat MAOModerat

    Monoamine oxidase inhibitors may result in increased hypotension. (label Brimonidin, Interaksi obat)

  • MetoheksitalbarbituratModerat

    Use with CNS depressants may result in an additive or potentiating effect. (label Brimonidin, Interaksi obat)

  • Metokarbamolpelemas ototModerat

    Use with CNS depressants may result in an additive or potentiating effect. (label Brimonidin, Interaksi obat)

  • Metoklopramidantagonis dopaminModerat

    Use with CNS depressants may result in an additive or potentiating effect. (label Brimonidin, Interaksi obat)

  • Metolazondiuretik tiazidModerat

    Antihypertensives/Cardiac Glycosides Because brimonidine tartrate ophthalmic solution 0.1% and 0.15% may reduce blood pressure, caution in using drugs such as antihypertensives and/or cardiac glycosides with brimonidine tartrate ophthalmic solution 0.1% and 0.15% is advised. (label Brimonidin, Interaksi obat)

  • Metoprololpenyekat betaModerat

    Antihypertensives/Cardiac Glycosides Because brimonidine tartrate ophthalmic solution 0.1% and 0.15% may reduce blood pressure, caution in using drugs such as antihypertensives and/or cardiac glycosides with brimonidine tartrate ophthalmic solution 0.1% and 0.15% is advised. (label Brimonidin, Interaksi obat)

  • Metoprolol dan hidroklorotiazidpenyekat betaModerat

    Antihypertensives/Cardiac Glycosides Because brimonidine tartrate ophthalmic solution 0.1% and 0.15% may reduce blood pressure, caution in using drugs such as antihypertensives and/or cardiac glycosides with brimonidine tartrate ophthalmic solution 0.1% and 0.15% is advised. (label Brimonidin, Interaksi obat)

  • MetsuksimidantikonvulsanModerat

    Use with CNS depressants may result in an additive or potentiating effect. (label Brimonidin, Interaksi obat)

  • MidazolambenzodiazepinModerat

    Use with CNS depressants may result in an additive or potentiating effect. (label Brimonidin, Interaksi obat)

  • MinoksidilvasodilatorModerat

    Antihypertensives/Cardiac Glycosides Because brimonidine tartrate ophthalmic solution 0.1% and 0.15% may reduce blood pressure, caution in using drugs such as antihypertensives and/or cardiac glycosides with brimonidine tartrate ophthalmic solution 0.1% and 0.15% is advised. (label Brimonidin, Interaksi obat)

  • MirtazapinantidepresanModerat

    Use with CNS depressants may result in an additive or potentiating effect. (label Brimonidin, Interaksi obat)

  • Moeksiprilpenghambat ACEModerat

    Antihypertensives/Cardiac Glycosides Because brimonidine tartrate ophthalmic solution 0.1% and 0.15% may reduce blood pressure, caution in using drugs such as antihypertensives and/or cardiac glycosides with brimonidine tartrate ophthalmic solution 0.1% and 0.15% is advised. (label Brimonidin, Interaksi obat)

  • MorfinopioidModerat

    Use with CNS depressants may result in an additive or potentiating effect. (label Brimonidin, Interaksi obat)

  • Nadololpenyekat betaModerat

    Antihypertensives/Cardiac Glycosides Because brimonidine tartrate ophthalmic solution 0.1% and 0.15% may reduce blood pressure, caution in using drugs such as antihypertensives and/or cardiac glycosides with brimonidine tartrate ophthalmic solution 0.1% and 0.15% is advised. (label Brimonidin, Interaksi obat)

  • NalbufinopioidModerat

    Use with CNS depressants may result in an additive or potentiating effect. (label Brimonidin, Interaksi obat)

  • Naltrekson dan bupropionantagonis opioidModerat

    Caution is advised in patients taking tricyclic antidepressants which can affect the metabolism and uptake of circulating amines. (label Brimonidin, Interaksi obat)

  • Natrium oksibatdepresan SSPModerat

    Use with CNS depressants may result in an additive or potentiating effect. (label Brimonidin, Interaksi obat)

  • Nebivololpenyekat betaModerat

    Antihypertensives/Cardiac Glycosides Because brimonidine tartrate ophthalmic solution 0.1% and 0.15% may reduce blood pressure, caution in using drugs such as antihypertensives and/or cardiac glycosides with brimonidine tartrate ophthalmic solution 0.1% and 0.15% is advised. (label Brimonidin, Interaksi obat)

  • NefazodonantidepresanModerat

    Caution is advised in patients taking tricyclic antidepressants which can affect the metabolism and uptake of circulating amines. (label Brimonidin, Interaksi obat)

  • Nifedipinpenghambat kanal kalsium dihidropiridinModerat

    Antihypertensives/Cardiac Glycosides Because brimonidine tartrate ophthalmic solution 0.1% and 0.15% may reduce blood pressure, caution in using drugs such as antihypertensives and/or cardiac glycosides with brimonidine tartrate ophthalmic solution 0.1% and 0.15% is advised. (label Brimonidin, Interaksi obat)

  • Nikardipinpenghambat kanal kalsium dihidropiridinModerat

    Antihypertensives/Cardiac Glycosides Because brimonidine tartrate ophthalmic solution 0.1% and 0.15% may reduce blood pressure, caution in using drugs such as antihypertensives and/or cardiac glycosides with brimonidine tartrate ophthalmic solution 0.1% and 0.15% is advised. (label Brimonidin, Interaksi obat)

  • Nisoldipinpenghambat kanal kalsium dihidropiridinModerat

    Antihypertensives/Cardiac Glycosides Because brimonidine tartrate ophthalmic solution 0.1% and 0.15% may reduce blood pressure, caution in using drugs such as antihypertensives and/or cardiac glycosides with brimonidine tartrate ophthalmic solution 0.1% and 0.15% is advised. (label Brimonidin, Interaksi obat)

  • NitroprusidvasodilatorModerat

    Antihypertensives/Cardiac Glycosides Because brimonidine tartrate ophthalmic solution 0.1% and 0.15% may reduce blood pressure, caution in using drugs such as antihypertensives and/or cardiac glycosides with brimonidine tartrate ophthalmic solution 0.1% and 0.15% is advised. (label Brimonidin, Interaksi obat)

  • Nortriptilinantidepresan trisiklikModerat

    Use with CNS depressants may result in an additive or potentiating effect. (label Brimonidin, Interaksi obat)

  • OksazepambenzodiazepinModerat

    Use with CNS depressants may result in an additive or potentiating effect. (label Brimonidin, Interaksi obat)

  • OksikodonopioidModerat

    Use with CNS depressants may result in an additive or potentiating effect. (label Brimonidin, Interaksi obat)

  • Oksikodon dan parasetamolopioidModerat

    Use with CNS depressants may result in an additive or potentiating effect. (label Brimonidin, Interaksi obat)

  • OksimorfonopioidModerat

    Use with CNS depressants may result in an additive or potentiating effect. (label Brimonidin, Interaksi obat)

  • OkskarbazepinantikonvulsanModerat

    Use with CNS depressants may result in an additive or potentiating effect. (label Brimonidin, Interaksi obat)

  • OlanzapinantipsikotikModerat

    Use with CNS depressants may result in an additive or potentiating effect. (label Brimonidin, Interaksi obat)

  • Olanzapin dan fluoksetinantipsikotikModerat

    Use with CNS depressants may result in an additive or potentiating effect. (label Brimonidin, Interaksi obat)

  • OliseridinopioidModerat

    Use with CNS depressants may result in an additive or potentiating effect. (label Brimonidin, Interaksi obat)

  • Olmesartanpenghambat reseptor angiotensin II (ARB)Moderat

    Antihypertensives/Cardiac Glycosides Because brimonidine tartrate ophthalmic solution 0.1% and 0.15% may reduce blood pressure, caution in using drugs such as antihypertensives and/or cardiac glycosides with brimonidine tartrate ophthalmic solution 0.1% and 0.15% is advised. (label Brimonidin, Interaksi obat)

  • Olmesartan dan hidroklorotiazidpenghambat reseptor angiotensin II (ARB)Moderat

    Antihypertensives/Cardiac Glycosides Because brimonidine tartrate ophthalmic solution 0.1% and 0.15% may reduce blood pressure, caution in using drugs such as antihypertensives and/or cardiac glycosides with brimonidine tartrate ophthalmic solution 0.1% and 0.15% is advised. (label Brimonidin, Interaksi obat)

  • Olmesartan, amlodipin, dan hidroklorotiazidpenghambat reseptor angiotensin II (ARB)Moderat

    Antihypertensives/Cardiac Glycosides Because brimonidine tartrate ophthalmic solution 0.1% and 0.15% may reduce blood pressure, caution in using drugs such as antihypertensives and/or cardiac glycosides with brimonidine tartrate ophthalmic solution 0.1% and 0.15% is advised. (label Brimonidin, Interaksi obat)

  • Orfenadrinpelemas ototModerat

    Use with CNS depressants may result in an additive or potentiating effect. (label Brimonidin, Interaksi obat)

  • Orfenadrin, aspirin, dan kafeinpelemas ototModerat

    Use with CNS depressants may result in an additive or potentiating effect. (label Brimonidin, Interaksi obat)

  • PaliperidonantipsikotikModerat

    Use with CNS depressants may result in an additive or potentiating effect. (label Brimonidin, Interaksi obat)

  • Parasetamol dan kodeinopioidModerat

    Use with CNS depressants may result in an additive or potentiating effect. (label Brimonidin, Interaksi obat)

  • ParoksetinSSRIModerat

    Caution is advised in patients taking tricyclic antidepressants which can affect the metabolism and uptake of circulating amines. (label Brimonidin, Interaksi obat)

  • Pentazosin dan naloksonopioidModerat

    Use with CNS depressants may result in an additive or potentiating effect. (label Brimonidin, Interaksi obat)

  • PerampanelantikonvulsanModerat

    Use with CNS depressants may result in an additive or potentiating effect. (label Brimonidin, Interaksi obat)

  • PerfenazinantipsikotikModerat

    Use with CNS depressants may result in an additive or potentiating effect. (label Brimonidin, Interaksi obat)

  • Perindoprilpenghambat ACEModerat

    Antihypertensives/Cardiac Glycosides Because brimonidine tartrate ophthalmic solution 0.1% and 0.15% may reduce blood pressure, caution in using drugs such as antihypertensives and/or cardiac glycosides with brimonidine tartrate ophthalmic solution 0.1% and 0.15% is advised. (label Brimonidin, Interaksi obat)

  • PetidinopioidModerat

    Use with CNS depressants may result in an additive or potentiating effect. (label Brimonidin, Interaksi obat)

  • PimavanserinantipsikotikModerat

    Use with CNS depressants may result in an additive or potentiating effect. (label Brimonidin, Interaksi obat)

  • PimozidantipsikotikModerat

    Use with CNS depressants may result in an additive or potentiating effect. (label Brimonidin, Interaksi obat)

  • Pindololpenyekat betaModerat

    Antihypertensives/Cardiac Glycosides Because brimonidine tartrate ophthalmic solution 0.1% and 0.15% may reduce blood pressure, caution in using drugs such as antihypertensives and/or cardiac glycosides with brimonidine tartrate ophthalmic solution 0.1% and 0.15% is advised. (label Brimonidin, Interaksi obat)

  • Pramipeksolagonis dopaminModerat

    Use with CNS depressants may result in an additive or potentiating effect. (label Brimonidin, Interaksi obat)

  • Prazosinpenyekat alfaModerat

    Antihypertensives/Cardiac Glycosides Because brimonidine tartrate ophthalmic solution 0.1% and 0.15% may reduce blood pressure, caution in using drugs such as antihypertensives and/or cardiac glycosides with brimonidine tartrate ophthalmic solution 0.1% and 0.15% is advised. (label Brimonidin, Interaksi obat)

  • PregabalinantikonvulsanModerat

    Use with CNS depressants may result in an additive or potentiating effect. (label Brimonidin, Interaksi obat)

  • PrimidonantikonvulsanModerat

    Use with CNS depressants may result in an additive or potentiating effect. (label Brimonidin, Interaksi obat)

  • ProklorperazinantipsikotikModerat

    Use with CNS depressants may result in an additive or potentiating effect. (label Brimonidin, Interaksi obat)

  • PrometazinantihistaminModerat

    Use with CNS depressants may result in an additive or potentiating effect. (label Brimonidin, Interaksi obat)

  • Prometazin dan dekstrometorfanantihistaminModerat

    Use with CNS depressants may result in an additive or potentiating effect. (label Brimonidin, Interaksi obat)

  • Prometazin dan kodeinopioidModerat

    Use with CNS depressants may result in an additive or potentiating effect. (label Brimonidin, Interaksi obat)

  • Propofoldepresan SSPModerat

    Use with CNS depressants may result in an additive or potentiating effect. (label Brimonidin, Interaksi obat)

  • Propranololpenyekat betaModerat

    Antihypertensives/Cardiac Glycosides Because brimonidine tartrate ophthalmic solution 0.1% and 0.15% may reduce blood pressure, caution in using drugs such as antihypertensives and/or cardiac glycosides with brimonidine tartrate ophthalmic solution 0.1% and 0.15% is advised. (label Brimonidin, Interaksi obat)

  • Protriptilinantidepresan trisiklikModerat

    Use with CNS depressants may result in an additive or potentiating effect. (label Brimonidin, Interaksi obat)

  • Ramelteonsedatif-hipnotikModerat

    Use with CNS depressants may result in an additive or potentiating effect. (label Brimonidin, Interaksi obat)

  • Ramiprilpenghambat ACEModerat

    Antihypertensives/Cardiac Glycosides Because brimonidine tartrate ophthalmic solution 0.1% and 0.15% may reduce blood pressure, caution in using drugs such as antihypertensives and/or cardiac glycosides with brimonidine tartrate ophthalmic solution 0.1% and 0.15% is advised. (label Brimonidin, Interaksi obat)

  • Rasagilinpenghambat MAOModerat

    Monoamine oxidase inhibitors may result in increased hypotension. (label Brimonidin, Interaksi obat)

  • RemifentanilopioidModerat

    Use with CNS depressants may result in an additive or potentiating effect. (label Brimonidin, Interaksi obat)

  • RisperidonantipsikotikModerat

    Use with CNS depressants may result in an additive or potentiating effect. (label Brimonidin, Interaksi obat)

  • Ropinirolagonis dopaminModerat

    Use with CNS depressants may result in an additive or potentiating effect. (label Brimonidin, Interaksi obat)

  • RufinamidantikonvulsanModerat

    Use with CNS depressants may result in an additive or potentiating effect. (label Brimonidin, Interaksi obat)

  • Sakubitril dan valsartanpenghambat reseptor angiotensin II (ARB)Moderat

    Antihypertensives/Cardiac Glycosides Because brimonidine tartrate ophthalmic solution 0.1% and 0.15% may reduce blood pressure, caution in using drugs such as antihypertensives and/or cardiac glycosides with brimonidine tartrate ophthalmic solution 0.1% and 0.15% is advised. (label Brimonidin, Interaksi obat)

  • Selegilinpenghambat MAOModerat

    Monoamine oxidase inhibitors may result in increased hypotension. (label Brimonidin, Interaksi obat)

  • SenobamatantikonvulsanModerat

    Use with CNS depressants may result in an additive or potentiating effect. (label Brimonidin, Interaksi obat)

  • SertralinSSRIModerat

    Caution is advised in patients taking tricyclic antidepressants which can affect the metabolism and uptake of circulating amines. (label Brimonidin, Interaksi obat)

  • Sevoflurananestetik umumModerat

    Use with CNS depressants may result in an additive or potentiating effect. (label Brimonidin, Interaksi obat)

  • Siklobenzaprinpelemas ototModerat

    Use with CNS depressants may result in an additive or potentiating effect. (label Brimonidin, Interaksi obat)

  • SiproheptadinantihistaminModerat

    Use with CNS depressants may result in an additive or potentiating effect. (label Brimonidin, Interaksi obat)

  • SitalopramSSRIModerat

    Caution is advised in patients taking tricyclic antidepressants which can affect the metabolism and uptake of circulating amines. (label Brimonidin, Interaksi obat)

  • SkopolaminantikolinergikModerat

    Use with CNS depressants may result in an additive or potentiating effect. (label Brimonidin, Interaksi obat)

  • Spironolaktonantagonis aldosteronModerat

    Antihypertensives/Cardiac Glycosides Because brimonidine tartrate ophthalmic solution 0.1% and 0.15% may reduce blood pressure, caution in using drugs such as antihypertensives and/or cardiac glycosides with brimonidine tartrate ophthalmic solution 0.1% and 0.15% is advised. (label Brimonidin, Interaksi obat)

  • Spironolakton dan hidroklorotiazidantagonis aldosteronModerat

    Antihypertensives/Cardiac Glycosides Because brimonidine tartrate ophthalmic solution 0.1% and 0.15% may reduce blood pressure, caution in using drugs such as antihypertensives and/or cardiac glycosides with brimonidine tartrate ophthalmic solution 0.1% and 0.15% is advised. (label Brimonidin, Interaksi obat)

  • Suvoreksantsedatif-hipnotikModerat

    Use with CNS depressants may result in an additive or potentiating effect. (label Brimonidin, Interaksi obat)

  • TapentadolopioidModerat

    Use with CNS depressants may result in an additive or potentiating effect. (label Brimonidin, Interaksi obat)

  • Tasimelteonsedatif-hipnotikModerat

    Use with CNS depressants may result in an additive or potentiating effect. (label Brimonidin, Interaksi obat)

  • Telmisartanpenghambat reseptor angiotensin II (ARB)Moderat

    Antihypertensives/Cardiac Glycosides Because brimonidine tartrate ophthalmic solution 0.1% and 0.15% may reduce blood pressure, caution in using drugs such as antihypertensives and/or cardiac glycosides with brimonidine tartrate ophthalmic solution 0.1% and 0.15% is advised. (label Brimonidin, Interaksi obat)

  • Telmisartan dan amlodipinpenghambat reseptor angiotensin II (ARB)Moderat

    Antihypertensives/Cardiac Glycosides Because brimonidine tartrate ophthalmic solution 0.1% and 0.15% may reduce blood pressure, caution in using drugs such as antihypertensives and/or cardiac glycosides with brimonidine tartrate ophthalmic solution 0.1% and 0.15% is advised. (label Brimonidin, Interaksi obat)

  • Telmisartan dan hidroklorotiazidpenghambat reseptor angiotensin II (ARB)Moderat

    Antihypertensives/Cardiac Glycosides Because brimonidine tartrate ophthalmic solution 0.1% and 0.15% may reduce blood pressure, caution in using drugs such as antihypertensives and/or cardiac glycosides with brimonidine tartrate ophthalmic solution 0.1% and 0.15% is advised. (label Brimonidin, Interaksi obat)

  • TemazepambenzodiazepinModerat

    Use with CNS depressants may result in an additive or potentiating effect. (label Brimonidin, Interaksi obat)

  • Terazosinpenyekat alfaModerat

    Antihypertensives/Cardiac Glycosides Because brimonidine tartrate ophthalmic solution 0.1% and 0.15% may reduce blood pressure, caution in using drugs such as antihypertensives and/or cardiac glycosides with brimonidine tartrate ophthalmic solution 0.1% and 0.15% is advised. (label Brimonidin, Interaksi obat)

  • Tetrabenazinpenghambat VMAT2Moderat

    Use with CNS depressants may result in an additive or potentiating effect. (label Brimonidin, Interaksi obat)

  • TiagabinantikonvulsanModerat

    Use with CNS depressants may result in an additive or potentiating effect. (label Brimonidin, Interaksi obat)

  • TioridazinantipsikotikModerat

    Use with CNS depressants may result in an additive or potentiating effect. (label Brimonidin, Interaksi obat)

  • TiotiksenantipsikotikModerat

    Use with CNS depressants may result in an additive or potentiating effect. (label Brimonidin, Interaksi obat)

  • Tizanidinpelemas ototModerat

    Use with CNS depressants may result in an additive or potentiating effect. (label Brimonidin, Interaksi obat)

  • TopiramatantikonvulsanModerat

    Use with CNS depressants may result in an additive or potentiating effect. (label Brimonidin, Interaksi obat)

  • Torasemiddiuretik loopModerat

    Antihypertensives/Cardiac Glycosides Because brimonidine tartrate ophthalmic solution 0.1% and 0.15% may reduce blood pressure, caution in using drugs such as antihypertensives and/or cardiac glycosides with brimonidine tartrate ophthalmic solution 0.1% and 0.15% is advised. (label Brimonidin, Interaksi obat)

  • TramadolopioidModerat

    Use with CNS depressants may result in an additive or potentiating effect. (label Brimonidin, Interaksi obat)

  • Tramadol dan parasetamolopioidModerat

    Use with CNS depressants may result in an additive or potentiating effect. (label Brimonidin, Interaksi obat)

  • Trandolaprilpenghambat ACEModerat

    Antihypertensives/Cardiac Glycosides Because brimonidine tartrate ophthalmic solution 0.1% and 0.15% may reduce blood pressure, caution in using drugs such as antihypertensives and/or cardiac glycosides with brimonidine tartrate ophthalmic solution 0.1% and 0.15% is advised. (label Brimonidin, Interaksi obat)

  • Tranilsiprominpenghambat MAOModerat

    Monoamine oxidase inhibitors may result in increased hypotension. (label Brimonidin, Interaksi obat)

  • TrazodonantidepresanModerat

    Use with CNS depressants may result in an additive or potentiating effect. (label Brimonidin, Interaksi obat)

  • Triamterendiuretik hemat kaliumModerat

    Antihypertensives/Cardiac Glycosides Because brimonidine tartrate ophthalmic solution 0.1% and 0.15% may reduce blood pressure, caution in using drugs such as antihypertensives and/or cardiac glycosides with brimonidine tartrate ophthalmic solution 0.1% and 0.15% is advised. (label Brimonidin, Interaksi obat)

  • Triamteren dan hidroklorotiaziddiuretik hemat kaliumModerat

    Antihypertensives/Cardiac Glycosides Because brimonidine tartrate ophthalmic solution 0.1% and 0.15% may reduce blood pressure, caution in using drugs such as antihypertensives and/or cardiac glycosides with brimonidine tartrate ophthalmic solution 0.1% and 0.15% is advised. (label Brimonidin, Interaksi obat)

  • TriazolambenzodiazepinModerat

    Use with CNS depressants may result in an additive or potentiating effect. (label Brimonidin, Interaksi obat)

  • TrifluoperazinantipsikotikModerat

    Use with CNS depressants may result in an additive or potentiating effect. (label Brimonidin, Interaksi obat)

  • Trimipraminantidepresan trisiklikModerat

    Use with CNS depressants may result in an additive or potentiating effect. (label Brimonidin, Interaksi obat)

  • Valsartanpenghambat reseptor angiotensin II (ARB)Moderat

    Antihypertensives/Cardiac Glycosides Because brimonidine tartrate ophthalmic solution 0.1% and 0.15% may reduce blood pressure, caution in using drugs such as antihypertensives and/or cardiac glycosides with brimonidine tartrate ophthalmic solution 0.1% and 0.15% is advised. (label Brimonidin, Interaksi obat)

  • Valsartan dan hidroklorotiazidpenghambat reseptor angiotensin II (ARB)Moderat

    Antihypertensives/Cardiac Glycosides Because brimonidine tartrate ophthalmic solution 0.1% and 0.15% may reduce blood pressure, caution in using drugs such as antihypertensives and/or cardiac glycosides with brimonidine tartrate ophthalmic solution 0.1% and 0.15% is advised. (label Brimonidin, Interaksi obat)

  • VenlafaksinSNRIModerat

    Caution is advised in patients taking tricyclic antidepressants which can affect the metabolism and uptake of circulating amines. (label Brimonidin, Interaksi obat)

  • Verapamilpenghambat kanal kalsiumModerat

    Antihypertensives/Cardiac Glycosides Because brimonidine tartrate ophthalmic solution 0.1% and 0.15% may reduce blood pressure, caution in using drugs such as antihypertensives and/or cardiac glycosides with brimonidine tartrate ophthalmic solution 0.1% and 0.15% is advised. (label Brimonidin, Interaksi obat)

  • VigabatrinantikonvulsanModerat

    Use with CNS depressants may result in an additive or potentiating effect. (label Brimonidin, Interaksi obat)

  • VilazodonSSRIModerat

    Caution is advised in patients taking tricyclic antidepressants which can affect the metabolism and uptake of circulating amines. (label Brimonidin, Interaksi obat)

  • VortioksetinantidepresanModerat

    Caution is advised in patients taking tricyclic antidepressants which can affect the metabolism and uptake of circulating amines. (label Brimonidin, Interaksi obat)

  • Zaleplonsedatif-hipnotikModerat

    Use with CNS depressants may result in an additive or potentiating effect. (label Brimonidin, Interaksi obat)

  • ZiprasidonantipsikotikModerat

    Use with CNS depressants may result in an additive or potentiating effect. (label Brimonidin, Interaksi obat)

  • Zolpidemsedatif-hipnotikModerat

    Use with CNS depressants may result in an additive or potentiating effect. (label Brimonidin, Interaksi obat)

  • ZonisamidantikonvulsanModerat

    Use with CNS depressants may result in an additive or potentiating effect. (label Brimonidin, Interaksi obat)

Penyebutan minor (1)

  • OksimetazolindekongestanMinor

    Alpha-adrenergic agonists as a class may impact blood pressure. (label Oksimetazolin, Peringatan dan perhatian)

Periksa Brimonidin terhadap semua yang Anda gunakan. Tambahkan seluruh daftar Anda; setiap pasangan diperiksa sekaligus.

Buka di pemeriksa

Bukan nasihat medis. Tingkat keparahan mencerminkan kata-kata dalam label, bukan keadaan Anda. Tanda “mayor” bisa merupakan hal yang rutin di bawah pengawasan, dan tanda “minor” bisa menjadi penting pada dosis tinggi. Tanyakan kepada apoteker.